[ET Net News Agency, 19 August 2019] Livzon Pharmaceutical Group Inc. (01513) said its
net profit attributable to shareholders of the company was RMB738.95 million for the six
months ended 30 June 2019, a year-on-year increase of 16.67%. The earnings per share were
RMB1.03. No dividend will be distributed.
The operating income was RMB4.94 billion, a year-on-year increase of 8.2%. (RC)